Which sector has the biggest momentum heading into earnings season?

The ASX 200 also posted a healthy gain over the month.

| More on:
A group of people excitedly cheering at a horse race.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some Australian market sectors are performing stronger than others as we head further into earnings season.  

The S&P/ASX 200 Index (ASX: XJO) posted a healthy 2.4% gain in July, while the All Ordinaries Index (ASX: XAO) climbed 2.6% higher over the month, Macquarie Group Ltd (ASX: MQG) data reveals.

"Australian equities rose in July, with the ASX 200 up +2.4%. The key theme of the month was the rotation from leaders to laggards, a phenomenon that often occurs at the start of a new financial year," Macquarie said in a note to investors.

The S&P/ASX 200 Resources Index (ASX: XJR) gained 4.5% over the month.

"Resources (+4.5%) had a strong month, supported by a rise in commodity prices," Macquarie said.

The strength in Industrial resources was relatively broad, with strength across Iron Ore. Fortescue Ltd (ASX: FMG) shares gained 16%.

Lithium, oil & gas, and Coal increases also supported the monthly gains. Mineral Resources Ltd (ASX: MIN) shares climbed 33% and Pilbara Minerals Ltd (ASX: PLS) shares increased 20%. 

Woodside Energy Group Ltd (ASX: WDS) shares climbed 13% higher, and Whitehaven Coal Ltd (ASX: WHC) shares jumped 19%.

"Consistent with the strength in Resources, China's stocks outperformed +3.5%," the broker said.

Strongest momentum by sector

By sector, health came out on top as the clear winner. The S&P/ASX 200 Health Care Index (ASX: XHJ) climbed 8.7% over the course of July, drastically outpacing the benchmark

The sector's gains were driven by index heavyweight CSL Ltd (ASX: CSL) shares, which climbed 13%.

"[CSL] was likely a key beneficiary of investors shifting some large cap money out of banks," the broker note said. 

Pro Medicus Ltd (ASX: PME) and Resmed Inc (ASX: RMD) shares were also strong performers. The share prices increased by 13% and 8%, respectively.

The energy, technology, and utilities sectors came next in line. The S&P/ASX 200 Energy Index (ASX: XEJ) jumped 5.4% over the month. The S&P/ASX 200 Information Technology Index (ASX: XIJ) and S&P/ASX 200 Utilities Index (ASX: XUJ) climbed 5.2% and 5.1% higher, respectively.

The S&P/ASX 200 Materials Index (ASX: XMJ) climbed 4.1% in July, while the S&P/ASX 200 Real Estate Index (ASX: XRE) and the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) rose by 3.2% and 3%, respectively.

Industrials and communication services posted some gains over the course of the month, albeit at a lower level. The S&P/ASX 200 Industrials Index (ASX: XNJ) rose by 2.7% and the S&P/ASX 200 Communication Services Index (ASX: XTJ) increased by 2.2%. 

Meanwhile, the worst-performing ASX sector was financials, with the S&P/ASX 200 Financials Index (ASX: XFJ) falling 1%.

The second-worst sector was consumer staples, with the S&P/ASX 200 Consumer Staples Index (ASX: XSJ) posting a small 0.4% gain.

Macquarie's outlook

The broker said in its note to investors:

Our bottom-up FY25 EPSg forecast is a decline of 3.2%. If this proves correct, it will be the third year in a row of declining earnings. At this point, our team forecast a relatively weak EPSg rebound of +2.2% in FY26. Unfortunately, August is typically the peak month for downgrades, as conservative guidance re-sets the earnings bar lower. But driven by global rate cuts and economic momentum, we think Australia's economic activity will improve, and support earnings upgrades over FY26.

Seasonality outlook. After the positive returns that typically occur in July, the next two months are likely to be disappointing. Over the last decade, August has been the third worst for returns, while September is the worst (and usually negative). To the extent this negative seasonality plays out again in 2025, it would provide another opportunity for investors to buy in expectation of a pick-up in growth in FY26.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Sector

Two workers walking through a silver mine
Resources Shares

Why Unico Silver shares are jumping today after a big quarterly update

Unico Silver shares rise after a quarterly update highlights drilling progress and a strong cash position.

Read more »

Calculator and gold bars on Australian dollars, symbolising dividends.
Share Market News

Gold, silver hit new highs as US punishes Europe with tariffs over Greenland stance

The United States wants to buy Greenland for security purposes.

Read more »

a miniature moulded model of a man bent over with a pick working stands behind a sign that has lithium's scientific abbreviation 'Li' with the word lithium underneath it against a sparse bland background.
Materials Shares

Up 365% since April, should you buy the recent dip in Core Lithium shares?

Core Lithium shares hit one-year plus highs on 8 January before taking a tumble.

Read more »

Miner with thumbs up at mine
Gold

Broker picks 'winners amongst winners' in the gold sector

These names stand out from the pack, RBC Capital Markets says.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Mesoblast just cleared a key FDA hurdle. So why are investors exiting?

Mesoblast shares slide to a 2-month low despite positive FDA feedback on its lead cell therapy product.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Gold

Guess which surging ASX gold share is leaping another 18% today on high-grade results

Investors are piling into this small-cap ASX gold share today. But why?

Read more »

an attractive woman gives a time out signal with her hands, holding them in a T shape, indicating a trading halt.
Materials Shares

Why this ASX small cap has hit the pause button again

This ASX small cap is back in a trading halt, with the market waiting on details of a planned US…

Read more »

Materials Shares

ASX All Ords mining stock sinking on big Tesla news

The latest update from Elon Musk’s Tesla is pressuring this ASX mining stock today. But why?

Read more »